SAB Biotherapeutics, Inc.
SABS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001833214
No open-market purchases or sales by SAB Biotherapeutics, Inc. insiders were filed in the last 90 days; 87 institutions reported holding it in 13F filings for Q2 2026, worth $266.8M in total; no superinvestor holds it.
Other share classesSABSW
Q1 2024 vs. Q4 2023
How the institutions holding SAB Biotherapeutics, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 42 | 24 | −18 |
| SharesConverted for a 1-for-10 split | 3.56M | 3.34M | −219.3K (−6.2%) |
| Value | $24.5M | $15.2M | −$9.32M (−38.1%) |
New holders (3)
Institutions that held SAB Biotherapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 54,050 | $245.4K | 0.00% |
| Princeton Global Asset Management LLC | 500 | $2.27K | 0.00% |
| Harbour Investments, Inc. | 50 | $227 | 0.00% |
Sold out (21)
Institutions that held SAB Biotherapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Ra Capital Management, L.P. | 2,374,081 | $1.63M |
| First PREMIER Bank | 807,535 | $555.0K |
| Kestra Advisory Services, LLC | 88,000 | $60.5K |
| State Street Corp | 81,241 | $55.9K |
| Mariner, LLC | 69,000 | $47.4K |
| Renaissance Technologies LLC | 63,100 | $43.0K |
| Peapack Gladstone Financial Corp | 52,296 | $36.0K |
| Silver Oak Securities, Inc | 51,891 | $35.7K |
| Creative Planning | 47,518 | $32.7K |
| Northern Trust Corp | 44,476 | $30.6K |
| Citadel Advisors LLC | 16,719 | $11.5K |
| Charles Schwab Investment Management Inc | 16,238 | $11.2K |
| Nadler Financial Group, Inc. | 13,750 | $9.45K |
| Commonwealth Equity Services, LLC | 12,823 | $9.00K |
| 1st Source Bank | 10,000 | $6.88K |
| Baird Financial Group, Inc. | 10,000 | $6.88K |
| Elgethun Capital Management | 5,435 | $6.47K |
| LM Advisors LLC | 3,620 | $2.49K |
| UBS Group AG | 500 | $344 |
| FMR LLC | 343 | $236 |
| Bank of America Corp | 54 | $38 |